Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David Léger is active.

Publication


Featured researches published by David Léger.


PLOS ONE | 2014

A Systematic Review Characterizing On-Farm Sources of Campylobacter spp. for Broiler Chickens

Agnes Agunos; Lisa Waddell; David Léger; Eduardo N. Taboada

Campylobacter and antimicrobial-resistant Campylobacter are frequently isolated from broiler chickens worldwide. In Canada, campylobacteriosis is the third leading cause of enteric disease and the regional emergence of ciprofloxacin-resistant Campylobacter in broiler chickens has raised a public health concern. This study aimed to identify, critically appraise, and synthesize literature on sources of Campylobacter in broilers at the farm level using systematic review methodology. Literature searches were conducted in January 2012 and included electronic searches in four bibliographic databases. Relevant studies in French or English (n = 95) conducted worldwide in any year and all study designs were included. Risk of Bias and GRADE criteria endorsed by the Cochrane collaboration was used to assess the internal validity of the study and overall confidence in the meta-analysis. The categories for on-farm sources were: broiler breeders/vertical transfer (number of studies = 32), animals (n = 57), humans (n = 26), environment (n = 54), and water (n = 63). Only three studies examined the antimicrobial resistance profiles of Campylobacter from these on-farm sources. Subgroups of data by source and outcome were analyzed using random effect meta-analysis. The highest risk for contaminating a new flock appears to be a contaminated barn environment due to insufficient cleaning and disinfection, insufficient downtime, and the presence of an adjacent broiler flock. Effective biosecurity enhancements from physical barriers to restricting human movement on the farm are recommended for consideration to enhance local on-farm food safety programs. Improved sampling procedures and standardized laboratory testing are needed for comparability across studies. Knowledge gaps that should be addressed include farm-level drug use and antimicrobial resistance information, further evaluation of the potential for vertical transfer, and improved genotyping methods to strengthen our understanding of Campylobacter epidemiology in broilers at the farm-level. This systematic review emphasizes the importance of improved industry-level and on-farm risk management strategies to reduce pre-harvest Campylobacter in broilers.


Zoonoses and Public Health | 2010

Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) Farm Program: results from finisher pig surveillance.

A. Deckert; Sheryl P. Gow; L. Rosengren; David Léger; Brent P. Avery; Danielle Daignault; L. Dutil; Richard Reid-Smith; Rebecca Irwin

In 2006, the Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) Farm Program was implemented in sentinel grower‐finisher swine herds in Québec, Ontario, Manitoba, Saskatchewan and Alberta. Herds were visited 1–3 times annually. Faecal samples were collected from pens of close‐to‐market (CTM) weight (>80 kg) pigs and antimicrobial use (AMU) data were collected via questionnaires. Samples were cultured for generic Escherichia coli and Salmonella and tested for antimicrobial susceptibility. This paper describes the findings of this program between 2006 and 2008. Eighty‐nine, 115 and 96 herds participated in this program in 2006, 2007 and 2008 respectively. Over the 3 years, antimicrobial resistance (AMR) levels remained consistent. During this period, resistance to one or more antimicrobials was detected in 56–63% of the Salmonella spp. isolates and 84–86% of E. coli isolates. Resistance to five or more antimicrobials was detected in 13–23% of Salmonella and 12–13% of E. coli. Resistance to drugs classified as very important to human health (Category I) by the Veterinary Drug Directorate (VDD), Health Canada, was less than or equal to 1% in both organisms. AMU data were provided by 100 herds in 2007 and 95 herds in 2008. Nine herds in 2007 and five herds in 2008 reported no AMU. The most common route of antimicrobial administration (75–79% of herds) was via feed, predominantly macrolides/lincosamides (66–68% of herds). In both 2007 and 2008, the primary reasons given for macrolide/lincosamide use were disease prevention, growth promotion and treatment of enteric disease. The Category I antimicrobials, ceftiofur and virginiamycin were not used in feed or water in any herds in 2008, but virginiamycin was used in feed in two herds in 2007. Parenteral ceftiofur was used in 29 herds (29%) in 2007 and 20 herds (21%) in 2008. The reasons for ceftiofur use included treatment of lameness, respiratory disease and enteric disease.


Emerging Infectious Diseases | 2013

Ciprofloxacin-Resistant Campylobacter spp. in Retail Chicken, Western Canada

Agnes Agunos; David Léger; Brent P. Avery; E. Jane Parmley; Anne E. Deckert; Carolee Carson; Lucie Dutil

During 2005–2010, the Canadian Integrated Program for Antimicrobial Resistance Surveillance identified increased prevalence of ciprofloxacin (a fluororquinolone) resistance among Campylobacter isolates from retail chicken in British Columbia (4%–17%) and Saskatchewan (6%–11%), Canada. Fluoroquinolones are critically important to human medicine and are not labeled for use in poultry in Canada.


Preventive Veterinary Medicine | 2013

Identifying associations in Escherichia coli antimicrobial resistance patterns using additive Bayesian networks

Antoinette Ludwig; Philippe Berthiaume; Patrick Boerlin; Sheryl Gow; David Léger; Fraser I. Lewis

While the genesis of antimicrobial resistance (AMR) in animal production is a high profile topic in the media and the scientific community, it is still not well understood. The epidemiology of AMR is complex. This complexity is demonstrated by extensive biological and evolutionary mechanisms which are potentially impacted by farm management and husbandry practices - the risk factors. Many parts of this system have yet to be fully described. Notably, the occurrence of multiple resistance patterns is the rule rather than exception - the multivariate problem. A first essential step in the development of any comprehensive risk factor analysis - whose goal is the prevention or reduction of AMR - is to describe those associations between different patterns of resistance which are systematic. That is, have sufficient statistical support for these patterns to be considered robust features of the underlying epidemiological system, and whose presence must therefore be incorporated into any risk factor analysis of AMR for it to be meaningful with respect to the farm environment. Presented here is a case study that seeks to identify systematic associations between patterns of resistance to 13 different antimicrobials in Escherichia coli isolates obtained from composite finisher (>80 kg) pig faecal samples obtained from Canadas five major pork producing provinces. The use of a Bayesian network analysis approach allowed us to identify many systematic associations between individual antimicrobial resistances. Sixteen of these resistances are corroborated with existing literature. These associations are distributed between several important classes of antimicrobials including the β-lactams, folate biosynthesis inhibitors, tetracyclines, aminoglycosides and quinolones. This study presents an exciting first step towards the larger and far more ambitious goal of developing generic and holistic risk factor analyses for on-farm occurrence of AMR. Analyses of this nature would combine multivariate response variables (joint patterns of resistance) with multi-factorial causal factors from within the livestock production environment thereby permitting a more complete understanding of the epidemiology of antimicrobial resistance.


PLOS ONE | 2017

Antimicrobial use surveillance in broiler chicken flocks in Canada, 2013-2015

Agnes Agunos; David Léger; Carolee Carson; Sheryl P. Gow; Angelina Bosman; Rebecca Irwin; Richard J. Reid-Smith

There is a paucity of data on the reason for and the quantity of antimicrobials used in broiler chickens in Canada. To address this, the Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) implemented surveillance of antimicrobial use (AMU) and antimicrobial resistance (AMR) in broiler chicken flocks in 2013. Shortly after this (2014), the poultry industry banned the preventive use of ceftiofur in broiler chickens. The objectives of this analysis were to describe antimicrobial use (AMU) in Canadian broiler chickens between 2013 and 2015 (n = 378 flocks), compare these results to other animal species in Canada, to highlight the utility of farm surveillance data to evaluate the impact of a policy change, and to explore how different antimicrobial use metrics might affect data interpretation and communication. The surveillance data indicated that the poultry industry policy resulted in lower antimicrobial use and resistance, and they successfully captured information on when, where, why, and how much antimicrobials were being used. The majority of antimicrobials were administered via the feed (95%). The relative frequency of antimicrobial classes used in broiler chickens differed from those used in swine or in food animal production in general. Coccidiostats were the most frequently used antimicrobial classes (53% of total kg). Excluding coccidiostats, the top three most frequently used antimicrobial classes were bacitracin (53% of flocks), virginiamycin (25%) and avilamycin (21%), mainly used for the prevention of necrotic enteritis. Depending on the AMU metric utilized, the relative rankings of the top antimicrobials changed; hence the choice of the AMU metric is an important consideration for any AMU reporting. When using milligrams/Population Correction Unit (mg/PCU) the top three antimicrobial classes used were bacitracins (76 mg/PCU), trimethoprim-sulfonamides (24 mg/PCU), and penicillins (15 mg/PCU), whereas when using a number of Defined Daily Doses in animals using Canadian standards /1,000 chicken-days at risk (nDDDvetCA/1,000 CD) the ranking was bacitracins (223 nDDDvetCA/1,000 CD), streptogramins (118 nDDDvetCA/1,000 CD), and trimethoprim-sulfonamides (87 nDDDvetCA/1,000 CD). The median animal treatment days in feed for one cycle (ATD/cycle) during the three-year study were 34 ATD/cycle; this was equal to the mean age of the flocks at pre-harvest sampling day (days at risk), indicating that the studied flocks except those that were raised without antibiotics and organic, were fed with medicated rations throughout the observation period. Overall, more than half (59%) of antimicrobials used in broiler chickens were in classes not used in human medicine, such as ionophores and chemical coccidiostats aimed to prevent coccidiosis. Compared to grower-finisher pigs and in production animal species (national sales data), the mg/PCU of antimicrobials used in broiler chickens was relatively lower. The findings of this paper highlighted the importance of farm-level AMU surveillance in measuring the impact of interventions to reduce antimicrobials in poultry.


Canadian Journal of Veterinary Research-revue Canadienne De Recherche Veterinaire | 2016

Farm-level prevalence and risk factors for detection of hepatitis E virus, porcine enteric calicivirus, and rotavirus in Canadian finisher pigs.

Barbara Wilhelm; Danielle Leblanc; David Léger; Sheryl P. Gow; Anne E. Deckert; David L. Pearl; Robert M. Friendship; Andrijana Rajić; Alain Houde; Scott A. McEwen


Online Journal of Public Health Informatics | 2015

CIPARS: A One-Health Approach to Antimicrobial Resistance Surveillance

Anne E. Deckert; Agnes Agunos; Brent P. Avery; Carolee Carson; Danielle Daignault; Rita Finley; Sheryl P. Gow; David Léger; Michael R. Mulvey; Jane Parmley; Richard J. Reid-Smith; Rebecca Irwin


Archive | 2012

ONE HEALTH AND FOOD SAFETY—THE CANADIAN EXPERIENCE: A HOLISTIC APPROACH TOWARD ENTERIC BACTERIAL PATHOGENS AND ANTIMICROBIAL RESISTANCE SURVEILLANCE

Jane Parmley; Zee Leung; David Léger; Rita Finley; Rebecca Irwin; Katarina Pintar; Frank Pollari; Richard J. Reid-Smith; David Waltner-Toews; Mohamad Karmali; Rainer Engelhardt


International Conference on the Epidemiology and Control of Biological, Chemical and Physical Hazards in Pigs and Pork | 2015

Antimicrobial use and resistance and the relationship with health and biosecurity status in CIPARS data from Canadian grower-finisher swine herds

Anne Deckert; Sheryl P. Gow; David Léger; Agnes Agunos; Richard Reid-Smith; Rebecca Irwin


Archive | 2010

Third call for proposals for Animal Health Strategic Investment - 9 new projects

Jane Gaviller-Fortune; George Charbonneau; Janet I. MacInnes; Zvonimir Poljak; Durda Slavic; Agnes Agunos; David Léger; Scott A. McEwen; Cynthia Philippe; Richard J. Reid-Smith; Luis G. Arroyo; Kristiina Ruotsalo; Paula Menzies; Jocelyn T. Jansen; Andria Q. Jones; Marina L. Brash; Laszlo Zsak; Susy Carman; Enrique de Castro; Robert M. Friendship; John R. Prescott; Vicki Nowell; Valeria R. Parreira

Collaboration


Dive into the David Léger's collaboration.

Top Co-Authors

Avatar

Agnes Agunos

Public Health Agency of Canada

View shared research outputs
Top Co-Authors

Avatar

Rebecca Irwin

Public Health Agency of Canada

View shared research outputs
Top Co-Authors

Avatar

Sheryl P. Gow

Public Health Agency of Canada

View shared research outputs
Top Co-Authors

Avatar

Brent P. Avery

Public Health Agency of Canada

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Carolee Carson

Public Health Agency of Canada

View shared research outputs
Top Co-Authors

Avatar

Danielle Daignault

Public Health Agency of Canada

View shared research outputs
Top Co-Authors

Avatar

Richard Reid-Smith

Public Health Agency of Canada

View shared research outputs
Top Co-Authors

Avatar

Anne Deckert

Public Health Agency of Canada

View shared research outputs
Researchain Logo
Decentralizing Knowledge